Longitudinal Registry of Endovascular Thoracoabdominal Aneurysms
LoRETA
1 other identifier
observational
1,000
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate the long-term safety and performance of complex endovascular aneurysm repair by inclusion in a longitudinal registry
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2018
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2018
CompletedFirst Posted
Study publicly available on registry
April 17, 2018
CompletedStudy Start
First participant enrolled
April 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedApril 17, 2018
April 1, 2018
2.8 years
April 9, 2018
April 9, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Longterm Aneurysm Related Mortality
Death attributed to aneurysm rupture
7 years
Interventions
Standard of care, treatment of thoracoabdominal aneurysms using endovascular techiniques.
Eligibility Criteria
All patients undergoing complex EVAR at study sites.
You may qualify if:
- Patient eligibility for enrolment shall be based on known information at the time of the procedure. Information obtained at a later date may contradict these criteria, but this will not be considered a deviation of the Study Plan.
- Patient requires endovascular repair of a thoracic, thoraco-abdominal or abdominal aortic or aorto-iliac aneurysm having morphology suitable for endovascular repair with complex endograft.
- Patients (or their legal representative for minor patients) who do not object to (oral non-objection declaration, and signed consent form) collection and transmission of his/her data.
You may not qualify if:
- Patients are excluded from enrolment into the study if any of the following are true:
- Patients whose imaging follow-up is impossible, i.e. patients who are not able to send their follow up CT scans or Duplex US
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tara Mastraccilead
- University Hospital, Lillecollaborator
- Skane University Hospitalcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 7 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Co-Investigator
Study Record Dates
First Submitted
April 9, 2018
First Posted
April 17, 2018
Study Start
April 30, 2018
Primary Completion
March 1, 2021
Study Completion
March 1, 2023
Last Updated
April 17, 2018
Record last verified: 2018-04